Pharmacare Pharmaceutics Limited 14453623 false 2022-11-01 2023-10-31 2023-10-31 The principal activity of the company is Wholesale of pharmaceutical goods Digita Accounts Production Advanced 6.30.9574.0 true 14453623 2022-11-01 2023-10-31 14453623 2023-10-31 14453623 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 14453623 bus:Micro-entities 2022-11-01 2023-10-31 14453623 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 14453623 bus:FilletedAccounts 2022-11-01 2023-10-31 14453623 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 14453623 bus:RegisteredOffice 2022-11-01 2023-10-31 14453623 bus:Director1 2022-11-01 2023-10-31 14453623 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 14453623 countries:AllCountries 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 14453623

Pharmacare Pharmaceutics Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2023

 

Pharmacare Pharmaceutics Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Pharmacare Pharmaceutics Limited

Company Information

Director

Ms Sara Sairafi

Registered office

21 Corporation Street
Walsall
Westy Midlands
WS1 4HW

Accountants

A Singh Accountancy
Mailbox 6, A Singh Accountancy Ltd
West Midlands House Ltd
Gipsy Lane
Willenhall
West Midlands
WV13 2HA

 

Pharmacare Pharmaceutics Limited

(Registration number: 14453623)
Balance Sheet as at 31 October 2023

2023
£

Current assets

29,975

Creditors: Amounts falling due within one year

(29,145)

 

830

Capital and reserves

830

1

General information

The company is a private company limited by share capital, incorporated in England & Wales .

The address of its registered office is:
21 Corporation Street
Walsall
Westy Midlands
WS1 4HW
England

These financial statements were authorised for issue by the director on 31 July 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0.

For the financial year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 31 July 2024
 

 

Pharmacare Pharmaceutics Limited

(Registration number: 14453623)
Balance Sheet as at 31 October 2023

.........................................
Ms Sara Sairafi
Director